Back to RTW INVESTMENTS, LP

APGE
Showing 8 of 11 quarters

Position history for RTW INVESTMENTS, LP's holdings in APOGEE THERAPEUTICS INC

RTW INVESTMENTS, LP holds 2.8M shares of APGE (APOGEE THERAPEUTICS INC), worth $234.2M as of 2026-Q1. The position was increased (+2.6% shares). APGE represents 2.3% of RTW INVESTMENTS, LP's portfolio.

Current Value

$234.2M

Current Shares

2.8M

Total Value Change

+$127.4M

Total Shares Change

+70,001

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.8M
+2.6%
$234.2M2.3%$68.50
54
2025-Q4
Unchanged
2.7M
0.0%
$204.7M2.1%$75.76
0
2025-Q3
Unchanged
2.7M
0.0%
$107.8M1.3%$39.83
0
2025-Q2
Unchanged
2.7M
0.0%
$117.8M1.7%$43.38
0
2025-Q1
Unchanged
2.7M
0.0%
$101.3M1.5%$39.72
0
2024-Q4
Increased
2.7M
0.0%
$122.9M1.9%$44.64
47
2024-Q3
Unchanged
2.7M
0.0%
$159.3M2.3%$57.99
0
2024-Q2
Increased
2.7M
+9.9%
$106.7M1.7%$39.35
52

Other major holders of APGE: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used